FGF21 discovery could lead to new treatments for type 2 diabetes
11 February 2016 | By Victoria White
New research on the blood lipid-lowering protein FGF21 shows how it redistributes fatty acids by two distinct mechanisms...
List view / Grid view
11 February 2016 | By Victoria White
New research on the blood lipid-lowering protein FGF21 shows how it redistributes fatty acids by two distinct mechanisms...
23 December 2015 | By Victoria White
ARA 290 is a first-in-class synthetic peptide designed to activate the innate repair mechanism in the setting of tissue injury...
14 December 2015 | By Victoria White
A new study outlines a way of using antibiotic resistance to find chemicals capable of stopping amyloid formation in amyloid diseases such as Parkinson’s, Alzheimer’s and type II diabetes...
11 December 2015 | By Victoria White
A new study shows how different pharmaceutical drugs hit either the "on" or "off" switch of β2AR - signalling protein linked to asthma, obesity and type 2 diabetes...
26 November 2015 | By Victoria White
Venom Knowledge Base summarises the results of 5,117 studies in the medical literature describing the use of venom toxins as painkillers and as treatments for diseases...
26 November 2015 | By Victoria White
Scientists from the University of Toronto have switched off, one by one, almost 18,000 genes - 90% of the entire human genome - to find the genes that are essential for cell survival...
16 November 2015 | By Victoria White
Investigators found that a protein called SIRT3 provides resistance to obesity-related inflammatory response...
10 November 2015 | By Victoria White
The initiative aims to accelerate research into biology's "invisible mass" to provide novel insights into cell function and a new frontier in drug discovery...
10 November 2015 | By Victoria White
Scientists from the University of New Mexico and NIH have created a cholesterol-lowering vaccine that leads to reductions in LDL cholesterol in mice and macaques...
4 November 2015 | By Victoria White
The discovery could represent a significant step forward in the battle against anaemia...
3 November 2015 | By Victoria White
The collaboration aims to understand factors mediating brain control of blood glucose and appetite with the ultimate goal of developing new therapeutic agents for the treatment of diabetes and obesity...
22 October 2015 | By Victoria White
Medlab will apply its nanotechnology delivery system to an existing statin compound, atorvastatin, for patients suffering high levels of cholesterol...
12 October 2015 | By Victoria White
Lilly has announced plans to add 30,000 square feet to its research and development site at the Alexandria Centre for Life Science in New York...
7 October 2015 | By Victoria White
C4XD’s most advanced compound, an oral Orexin-1 antagonist for the treatment of addiction, is in formal preclinical safety and toxicity studies...
2 October 2015 | By Victoria White
Scientists have discovered a protein that 'soaks up' the overproduced hormone that leads to diabetic enteropathy...